I2 INNOVATION IN INFLAMMATION Trademark

Trademark Overview

On Thursday, October 17, 2019, a trademark application was filed for I2 INNOVATION IN INFLAMMATION with the United States Patent and Trademark Office. The USPTO has given the I2 INNOVATION IN INFLAMMATION trademark a serial number of 88658481. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 18, 2022. This trademark is owned by Gilead Sciences, Inc.. The I2 INNOVATION IN INFLAMMATION trademark is filed in the Insurance & Financial Services category with the following description:

Providing grants for research in the medical and pharmaceutical fields; Providing grants for research related to inflammatory and autoimmune diseases and disorders
i2 innovation in inflammation

General Information

Serial Number88658481
Word MarkI2 INNOVATION IN INFLAMMATION
Filing DateThursday, October 17, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 18, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 21, 2020

Trademark Statements

Description of MarkThe mark consists of the lowercase letter "i" in red font and superscript "2" in gray on the left of the design, with a vertical red line separating the text "Innovation" in gray appearing directly over "IN INFLAMMATION" in the same gray text.
Pseudo MarkI TWO INNOVATION IN INFLAMMATION
Goods and ServicesProviding grants for research in the medical and pharmaceutical fields; Providing grants for research related to inflammatory and autoimmune diseases and disorders
Indication of Colors claimedThe color(s) red and gray is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"INFLAMMATION"

Classification Information

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, October 21, 2019
Primary Code036
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGilead Sciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFoster City, CA 94404
Party NameGilead Sciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFoster City, CA 94404

Trademark Events

Event DateEvent Description
Monday, April 18, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 18, 2022ABANDONMENT - NO USE STATEMENT FILED
Friday, July 30, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 28, 2021SOU EXTENSION 3 GRANTED
Wednesday, July 28, 2021SOU EXTENSION 3 FILED
Wednesday, July 28, 2021SOU TEAS EXTENSION RECEIVED
Thursday, January 7, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 5, 2021SOU EXTENSION 2 GRANTED
Tuesday, January 5, 2021SOU EXTENSION 2 FILED
Tuesday, January 5, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, August 18, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 14, 2020SOU EXTENSION 1 GRANTED
Friday, August 14, 2020SOU EXTENSION 1 FILED
Friday, August 14, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, March 17, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 21, 2020PUBLISHED FOR OPPOSITION
Wednesday, January 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, December 19, 2019ASSIGNED TO LIE
Monday, December 16, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, December 14, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 13, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 13, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 11, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 11, 2019NON-FINAL ACTION E-MAILED
Wednesday, December 11, 2019NON-FINAL ACTION WRITTEN
Tuesday, December 3, 2019ASSIGNED TO EXAMINER
Tuesday, October 22, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, October 21, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 21, 2019NEW APPLICATION ENTERED

Related Keywords

inflammation innovation research grants providing autoimmune disorders inflammatory diseases fields medical pharmaceutical